Related references
Note: Only part of the references are listed.Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats
E. M. Rock et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation
D. Bolognini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability
Lesley D. O'Brien et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
L. De Petrocellis et al.
ACTA PHYSIOLOGICA (2012)
Cannabidivarin is anticonvulsant in mouse and rat
A. J. Hill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
E. M. Rock et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour
Serena Deiana et al.
PSYCHOPHARMACOLOGY (2012)
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
C. Garcia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice
Daniele Bolognini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats
C. L. Limebeer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
N. L. Cluny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats
Andrew J. Hill et al.
EPILEPSIA (2010)
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
K. S. Sink et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
Comparative topical anti-inflammatory activity of cannabinoids and cannabivarins
Aurelia Tubaro et al.
FITOTERAPIA (2010)
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Joseph Tam et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Depression-like phenotype following chronic CB1 receptor antagonism
Chad E. Beyer et al.
NEUROBIOLOGY OF DISEASE (2010)
Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice
Gernot Riedel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Pleiotropic Effects of Rimonabant: Clinical Implications
Jean-Pierre Despres
CURRENT PHARMACEUTICAL DESIGN (2009)
Melancholic features related to rimonabant
Bernardo de Mattos Viana et al.
GENERAL HOSPITAL PSYCHIATRY (2009)
Potential of the rat model of conditioned gaping to detect nausea produced by rolipram, a phosphodiesterase-4 (PDE4) inhibitor
Erin M. Rock et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Antidepressant-like effects of paroxetine are produced by lower doses than those which produce nausea
Katharine J. Tuerke et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: Effects on food-reinforced behavior and comparisons with AM4113
K. S. Sink et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Effect of 5-HT3 antagonists and a 5-HT1A agonist on fluoxetine-induced conditioned gaping reactions in rats
Cheryl L. Limebeer et al.
PSYCHOPHARMACOLOGY (2009)
The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats
Kelly S. Sink et al.
NEUROPSYCHOPHARMACOLOGY (2008)
The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat
Erin M. Rock et al.
PSYCHOPHARMACOLOGY (2008)
Conditioned Nausea in Rats: Assessment by Conditioned Disgust Reactions, Rather Than Conditioned Taste Avoidance
Linda A. Parker et al.
CANADIAN JOURNAL OF EXPERIMENTAL PSYCHOLOGY-REVUE CANADIENNE DE PSYCHOLOGIE EXPERIMENTALE (2008)
The psychoactive plant cannabinoid, Delta(9)-tetrahydrocannabinol, is antagonized by Delta(8)- and Delta(9)-tetrahydrocannabivarin in mice in vivo
R. G. Pertwee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
A neutral CB1 receptor antagonist reduces weight gain in rat
Adam P. Chambers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret
K. A. Sharkey et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Effect of Δ9-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test
Maegan M. Jarrett et al.
PHYSIOLOGY & BEHAVIOR (2007)
Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat
Shelley K. Cross-Mellor et al.
PSYCHOPHARMACOLOGY (2007)
Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist
A Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Effect of Δ9-tetrahydrocannabinol on sucrose palatability as measured by the taste reactivity test
MM Jarrett et al.
PHYSIOLOGY & BEHAVIOR (2005)
The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats
PJ McLaughlin et al.
PSYCHOPHARMACOLOGY (2005)
A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae)
KW Hillig et al.
AMERICAN JOURNAL OF BOTANY (2004)
Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in rats
LA Parker et al.
INTEGRATIVE PHYSIOLOGICAL AND BEHAVIORAL SCIENCE (2003)
Cannabidiol: An overview of some pharmacological aspects
R Mechoulam et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats
LA Parker et al.
NEUROREPORT (2002)
Share Paper
